MarketCap
Facebook
X
TelegramQuarterly report 2024-Q3
added 11-14-2024
T2 Biosystems EV - Enterprise Value 2011-2026 | TTOO
Annual EV - Enterprise Value T2 Biosystems
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 54.9 M | 63.7 M | 52.5 M | 348 M | 96.1 M | 140 M | 171 M | 120 M | 148 M | 140 M | 91.2 M | 64.4 M | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 348 M | 52.5 M | 124 M |
EV - Enterprise Value of other stocks in the Diagnostics research industry
| Issuer | EV - Enterprise Value | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Akumin
AKU
|
1.64 B | - | -17.87 % | $ 25.9 M |  Canada |
|
Centogene N.V.
CNTG
|
-19.1 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Agilent Technologies
A
|
45.8 B | $ 114.87 | -0.65 % | $ 34.9 B |  USA |
 |
Accelerate Diagnostics
AXDX
|
92.6 M | - | -61.36 % | $ 2.46 M | USA |
 |
Chembio Diagnostics
CEMI
|
39.2 M | - | 0.22 % | $ 16.8 M | USA |
 |
Co-Diagnostics
CODX
|
-1.92 M | $ 1.61 | -2.35 % | $ 2.14 M | USA |
 |
Aspira Women's Health
AWH
|
10.6 M | - | -6.19 % | $ 10.5 M | USA |
 |
Biocept
BIOC
|
15 M | - | -13.05 % | $ 7.29 M | USA |
 |
Castle Biosciences
CSTL
|
665 M | $ 24.61 | -1.48 % | $ 684 M | USA |
 |
Check-Cap Ltd.
CHEK
|
2.55 M | - | - | $ 9.42 M |  Israel |
 |
Enzo Biochem
ENZ
|
-22.7 M | - | -8.98 % | $ 14.8 K | USA |
 |
CareDx, Inc
CDNA
|
1.04 B | $ 21.85 | - | $ 1.16 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
26.2 M | - | - | $ 562 M |  Britain |
 |
Illumina
ILMN
|
15.3 B | $ 126.55 | -1.54 % | $ 20.1 B | USA |
 |
DermTech
DMTK
|
70.4 M | - | -11.32 % | $ 2.94 M | USA |
 |
Exact Sciences Corporation
EXAS
|
22 B | - | - | $ 19.8 B | USA |
 |
Fulgent Genetics
FLGT
|
502 M | $ 15.29 | -1.99 % | $ 462 M | USA |
 |
HTG Molecular Diagnostics
HTGM
|
3.16 M | - | -20.0 % | $ 1.06 M | USA |
 |
Global Cord Blood Corporation
CO
|
-2.77 B | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
6.64 M | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
9.21 B | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
251 M | - | 0.12 % | $ 80.1 M | China |
 |
Lantheus Holdings
LNTH
|
5.9 B | $ 83.38 | -0.87 % | $ 5.63 B | USA |
 |
Charles River Laboratories International
CRL
|
11.4 B | $ 166.76 | -2.61 % | $ 8.27 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
5.02 B | - | - | $ 10.7 B | USA |
 |
Guardant Health
GH
|
15.2 B | $ 82.62 | -6.64 % | $ 10.4 B | USA |
 |
National Research Corporation
NRC
|
432 M | $ 16.99 | -0.73 % | $ 380 M | USA |
 |
Heska Corporation
HSKA
|
851 M | - | - | $ 1.31 B | USA |
 |
Interpace Biosciences
IDXG
|
16.3 M | $ 1.93 | - | $ 8.54 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
13.2 B | $ 27.13 | -1.49 % | $ 20 B |  Niderland |
 |
Precipio
PRPO
|
42.5 M | $ 30.2 | -1.64 % | $ 48.5 M | USA |
 |
Personalis
PSNL
|
229 M | $ 5.54 | -7.05 % | $ 328 M | USA |
 |
Senseonics Holdings
SENS
|
376 M | $ 7.28 | 0.14 % | $ 304 M | USA |
 |
Medpace Holdings
MEDP
|
14 B | $ 416.18 | -1.23 % | $ 12 B | USA |
 |
QIAGEN N.V.
QGEN
|
11.3 B | - | - | $ 10.6 B | Niderland |
 |
Motus GI Holdings
MOTS
|
568 K | - | -34.28 % | $ 263 K | Israel |
 |
Biomerica
BMRA
|
6.63 M | $ 2.13 | -2.06 % | $ 4.89 M | USA |
 |
ICON Public Limited Company
ICLR
|
26.4 B | $ 101.17 | -1.98 % | $ 8.34 B |  Irlanda |
 |
Laboratory Corporation of America Holdings
LH
|
33.1 B | $ 261.16 | -0.86 % | $ 21.7 B | USA |
 |
Thermo Fisher Scientific
TMO
|
186 B | $ 469.03 | 0.21 % | $ 177 B | USA |
 |
Trinity Biotech plc
TRIB
|
133 M | $ 0.62 | -3.8 % | $ 61.9 M | Irlanda |
 |
Neogen Corporation
NEOG
|
2.26 B | $ 9.29 | -1.75 % | $ 2.01 B | USA |
 |
Celcuity
CELC
|
5.57 B | $ 122.03 | -2.9 % | $ 5.71 B | USA |
 |
Twist Bioscience Corporation
TWST
|
1.55 B | $ 59.4 | -2.62 % | $ 3.55 B | USA |
 |
NeoGenomics
NEO
|
1.85 B | $ 8.67 | 0.7 % | $ 1.11 B | USA |
 |
Myriad Genetics
MYGN
|
598 M | $ 4.83 | -0.1 % | $ 447 M | USA |
 |
Natera
NTRA
|
5.53 B | $ 199.57 | -2.36 % | $ 19.6 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
22.9 B | $ 196.11 | -0.26 % | $ 21.8 B | USA |
 |
Invitae Corporation
NVTA
|
2.11 B | - | - | $ 21.2 M | USA |
 |
OpGen
OPGN
|
10.3 M | - | -16.95 % | $ 1.54 M | USA |